Securities

We do indeed live in interesting times. The world braces for the era of its first American-born pope; hundreds of...

As the United States raced into the new year with much uncertainty, we witnessed a new government that's intent on...

While the goal of this newsletter is to be effectively a March-only report, as we put it together, it is...

With the current administration (and a few government-adjacent billionaires) calling the shots, the immediate and distant future of all government...

In recent (and distant) memory, there's been little to celebrate in publicly traded cannabis-land. We might speculate that investors in...

As has been the case for longer than we care to remember, most of the CRB equity market failed its...

There's not much we can say about December’s performance of publicly traded cannabis equities that we have not said about...

The weeks, actually months, leading up to November 2024 carried an air of uncertainty for cannabis investors and other interested...

Co-authored by Kyle Buckley, Senior Analyst, CRB Monitor The 2024 general election resulted in Republican majorities in both houses of...

October was, as usual, a volatile month for cannabis equities as the November 5 elections loomed large throughout the month....